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Background-—Higher height and weight are known to be associated with higher risk of atrial ﬁbrillation (AF); however, whether the
risk of AF is related to abdominal obesity is unclear.
Methods and Results-—We studied 501 690 adults (mean age: 47.614.3 years; 250 664 women [50.0%]) without baseline AF in
the National Sample Cohort released by the National Health Insurance Service in Korea. Body mass index (underweight deﬁned as
<18.5; normal, 18.5 to <25.0; overweight, 25.0 to <30.0; and obese, ≥30.0) and waist circumference (abdominal obesity deﬁned
as ≥90 cm for men and ≥80 cm for women) were evaluated. During a mean follow-up of 3.91.3 years, 3443 participants (1432
women [41.6%]) developed AF. In multivariable models adjusted for clinical variables, the AF risk of underweight, overweight, and
obese individuals increased by 21% (95% conﬁdence interval, 1.01–1.45, P=0.043), 14% (95% conﬁdence interval, 1.06–1.23,
P<0.001), and 52% (95% conﬁdence interval, 1.30–1.78, P<0.001), respectively, compared with those with normal body mass
index. AF risk with confounder-adjusted hazards for abdominal obesity was 18% (95% conﬁdence interval, 1.10–1.27, P<0.001).
The increased AF risk was present in abdominally obese individuals regardless of body mass index except for the obese group. In
subgroup analysis, abdominal obesity by waist circumference conferred increased risk of new-onset AF, particularly in participants
without comorbidities.
Conclusions-—Abdominal obesity is an important, potentially modiﬁable risk factor for AF in nonobese Asian persons. These data
suggest that interventions to decrease abdominal obesity may reduce the population burden of AF. ( J Am Heart Assoc. 2017;6:
e004705. DOI: 10.1161/JAHA.116.004705.)
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A trial ﬁbrillation (AF) is a public health problem becausethe arrhythmia affects millions of people and predis-
poses to heart failure, dementia, stroke, and death.1–3 Higher
height, weight, and body mass index (BMI)4–7 confer
increased risk of AF. Importantly, general obesity, which is
one of a limited number of modiﬁable risk factors for AF, and
high BMI have been reported to be related to AF burden and
severity.8–11 The Framingham cohort study demonstrated a
signiﬁcant close relationship with increased risk of developing
AF with increasing severity of general obesity.7 In particular,
the dilated left atria observed in obese participants appear to
be mechanistically important, as the association between BMI
and AF was signiﬁcantly weakened when adjustments were
made for left atrial (LA) size in the Framingham study.7 LA
dilatation and atrial dysfunction are known consequences of
cardiomyopathy due to general obesity.12
Waist circumference (WC) and waist-to-hip circumference
ratio are also associated with higher risk of AF.4,13–15 Visceral
adiposity is associated with incident cardiovascular disease
after adjustment for clinical risk factors and generalized
adiposity.16 Previous studies, however, did not show addi-
tional risk of AF by abdominal obesity beyond BMI. The
prevalence of overweight status and obesity in Asian popu-
lations is lower than that in Western populations. Moreover,
Asian persons tend to have higher amounts of abdominal fat
at lower BMI compared with European persons.17 Neverthe-
less, assessments on whether the risk of AF is related to
abdominal obesity in the Asian population are limited.17,18 In
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this regard, we analyzed a recently developed Korean National
Health Insurance sample cohort database, which includes
>500 000 persons who had health examinations, to evaluate
the association between abdominal obesity and AF between
2009 and 2013. We also evaluated whether the association
was consistent regardless of participants’ BMI categories.
Methods
Study Population
A national health insurance system in Korea was estab-
lished in 1963 according to the National Health Insurance
Act, and participation is compulsory for all citizens in South
Korea. Currently, the National Health Insurance Service
(NHIS) maintains and manages all Korean health service
databases. The NHIS is also in charge of the national health
examination programs, which include a general health
examination for all insured employees or self-employed
persons aged >40 years and their dependents. The
examinations are recommended to be undertaken at least
biennially.
The NHIS released the National Sample Cohort (2002–
2013) database (NHIS-NSC [2002–2013]) in 2015. It consists
of 1 025 340 Koreans as an initial 2002 cohort and follows
the participants until 2013. The cohort data represent about
2.2% of the source population in 2002 (46 605 433). This
study enrolled 501 509 patients aged >18 years without AF
from the NHIS-NSC in 2009. These patients had physical
examination data including WC and analyzed follow-up data
until December 2014. The database is a semidynamic cohort
database; the cohort has been followed up to either the time
of the participant’s disqualiﬁcation from health services
because of death or emigration or the end of the study
period. Samples of newborn infants are included annually. The
database contains eligibility and demographic information
about health insurance and medical aid beneﬁciaries, medical
bill details, medical treatment, disease histories, and
prescriptions. Such data are constructed after converting
insurance claim information to the ﬁrst day of medical
treatment.
In the cohort, the disease information of the participants was
classiﬁed according to the International Classiﬁcation of
Diseases, 10th Revision (ICD-10) codes, and the mortality
information along with cause of death of the participants was
obtained from the KoreanNational Statistical Ofﬁce. Deﬁnitions
of diagnoses, comorbidity, and outcomes were evaluated based
on information from NHIS-NSC/Yonsei University (Table S1).
AF was diagnosed using ICD-10 codes (ICD-10:I48). To
ensure accurate diagnosis, we deﬁned patients with AF only
when it was a discharge diagnosis or was conﬁrmed more
than twice in the outpatient department.19–21 Furthermore,
the laboratory and survey questionnaire data of general and
life-transition health examinations for all cohort members
were combined. This study was based on NHIS data. Informed
consent was not obtained individually. Data were completely
anonymized and deidentiﬁed for analysis. Height, weight, and
WC were measured by a trained nurse during the physical
examination at a primary care unit or hospital clinic in charge
of the national health examination programs. WC was
measured between the lower margin of the last palpable rib
and the top of the iliac crest, at the level of maximum
circumference, using a ﬂexible inelastic ﬁberglass tape with
the tape parallel to the ﬂoor.22 BMI is deﬁned as the body
weight divided by the square of the body height (kg/m2).
Additional analysis was performed in 1037 consecutive AF
patients who were admitted to Severance Hospital from 2009
to 2015 to evaluate the relationship between LA size and BMI
or WC. LA enlargement was deﬁned as LA diameter >45 mm,
according to a previous study.23 Data from the NHIS and
Severance Hospital were used after approval by the institu-
tional review board of Yonsei University Hospital.
Statistical Analysis
BMI was analyzed as both continuous and categorical
variables using the World Health Organization/National
Institutes of Health classiﬁcation scheme (underweight
deﬁned as <18.5; normal, 18.5 to <25.0; overweight, 25.0
to <30.0; and obese, >30.0).24 WC was also evaluated as both
continuous and categorical variables (abdominal obesity
deﬁned as ≥90 cm for men and ≥80 cm for women).25 Data
are presented as meanSD for continuous variables and as
proportions for categorical variables. Continuous variables
were compared using the Student t test. Analysis of
categorical variables was performed with the v2 test.
Continuous variables were compared using 1-way ANOVA
and v2 test or Fisher exact test as a post hoc test for each
BMI group. The relationship among BMI, WC, and the
incidence of AF is graphically illustrated with smooth curves
Clinical Perspective
What Is New?
• In this Korean nationwide community-based cohort, abdom-
inal obesity and general obesity are associated with new-
onset AF after adjustment for other risk factors.
What Are the Clinical Implications?
• These ﬁndings suggest that improvement of abdominal
obesity may decrease the risk of AF in a nonobese Asian
population. Further investigation regarding abdominal obe-
sity and AF is needed.
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ﬁtted to a Cox proportional hazards model using a penalized
B-spline method. The splines among BMI, WC, and log hazard
rate of new-onset AF were adjusted for the relevant covariates
in the overall population and a sex-stratiﬁed population.
We examined the association amongBMI,WC, and the risk of
developing new-onset AF using Cox proportional hazards
regressions. We estimated the age-adjusted and multivariable
models. Covariates selected for adjustment included age, sex,
history of hypertension, diabetes mellitus, dyslipidemia, con-
gestive heart failure, chronic kidney disease or end-stage renal
disease, previous myocardial infarction (MI), transient ischemic
attack or stroke, heavy alcohol use, and status as a former or
current smoker.26,27 We deﬁned interim heart failure and MI as
events that occur after the baseline examination and before the
onset of AF and examined a Cox regression model adjusted for
them. The risk of new-onset AF was assessed according to
patients’ abdominal obesity using 4 BMI categories, and the risk
of AF incidence for BMI or WC was estimated using a model
adjusted according to age, sex, and clinical variables in the total
population. To examine the proportional assumption for the Cox
regression models, we analyzed the proportional hazards
assumption tested based on the scaled Schoenfeld residuals.
To evaluate the HR of abdominal obesity for new-onset AF
in patients with different comorbidities and habits of smoking
and alcohol, we analyzed the effect of abdominal obesity on
incident AF in subgroups. A heavy alcohol habit was deﬁned
as >1 drink per day for women and >2 drinks per day for
men.7 Linear regression analysis was performed to identify
relationships among BMI, WC, and LA size. The risk of BMI and
WC for LA enlargement was assessed using an age- and sex-
adjusted model of multivariate logistic regression analysis.
Kaplan–Meier survival curves were plotted for incidental AF
risk across categories of BMI and WC and compared by
means of a log-rank test. The population-attributable risks of
overweight status or obesity and abdominal obesity were
calculated by subtracting the rate of AF in the entire cohort
from the rate of AF in those who carried the risk factor and
dividing it by the rate of AF in the entire cohort.28,29
Statistical analysis using the Cox proportional hazards
model with a penalized B-spline method (Figure S1) and the
required proportional hazards assumption tested based on the
scaled Schoenfeld residuals was performed using R version
3.2.2 software. Other statistical analyses were performed
with SPSS 21.0 statistical software. All P values were 2-tailed,
and values <0.05 were considered statistically signiﬁcant.
Results
Study Participants
The mean age of the participants was 47.6 years (range: 18–
98 years). Of the 251 026 men, 83 955 (33.4%) were
overweight and 10 018 (4.0%) were obese; of the 250 664
women, 57 174 (22.8%) were overweight and 9078 (3.6%)
were obese. Mean BMI was 23.73.3, and mean WC was
80.09.4 cm. The baseline characteristics of the study
population by BMI level and WC category are presented in
Table 1. An increase in BMI resulted in increased proportions
of participants with hypertension, diabetes mellitus, and/or
heart failure (all P<0.001). Participants without abdominal
obesity had lower proportions of hypertension, diabetes
mellitus, and/or heart failure compared with those who had
abdominal obesity, as deﬁned by WC level (all P<0.001). There
were more men in the overweight and obese groups. In our
cohorts, of the 19 096 obese participants, 734 (3.8%) did not
have abdominal obesity and 18 331 (96.2%) did; of the
482 594 nonobese subjects, 358 182 (74.2%) did not have
abdominal obesity and 124 263 (25.8%) did.
AF Incidence
During a mean follow-up of 3.9 years, 3443 participants
(0.7%), including 2011 men (58.4%), developed AF. The overall
AF incidence for follow-up duration was 1.78 per 1000 per-
son-years. The incidence rates of AF by BMI or WC categories
are presented in Table 2. AF incidence in the obese and
overweight groups was higher compared with that in the
underweight and normal groups (P<0.001). AF incidence was
also higher among participants with abdominal obesity than in
those without (P<0.001).
Figure 1 shows the Kaplan–Meier curves for new-onset AF
in patients with different categories of BMI (Figure 1A) or WC
(Figure 1B). Patients in the obese and overweight groups
showed higher cumulative incidence of new-onset AF than
those in the normal and underweight groups (all P<0.001).
Patients with abdominal obesity had higher cumulative
incidence of new-onset AF than those without abdominal
obesity (P<0.001).
Risk of New-Onset AF According to BMI and WC
Adjusted results of the multivariable Cox proportional hazards
regressions for age, sex, and relevant cardiovascular risk
factors are shown in Table 3. After adjustment for age and
sex, each 1-SD increase in BMI (+3.7) or WC (+9.4 cm) was
associated with an increase of 17% (P<0.001) or 23%
(P<0.001), respectively. These relationships remained signif-
icant in multivariable-adjusted models, with 8% and 12%
increases in the risk of AF per 1-SD increase in BMI (P<0.001)
and WC (P<0.001), respectively.
Spline curves between BMI and WC and the hazard ratio
(HR) of new-onset AF are presented in Figure S1. A nonlinear
J-shaped association was found between continuous BMI
variables and AF risk; AF risk positively increased with the
DOI: 10.1161/JAHA.116.004705 Journal of the American Heart Association 3
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increase of WC. Interestingly, the overall J-shaped and linear
patterns in the association seem to be driven mainly by the
patterns for men.
To assess the inﬂuence of different degrees of BMI, we
estimated regressions with 4 BMI categories (underweight,
normal, overweight, and obese; Table 3). Age- and sex-
adjusted HRs for AF progressively increased across these 4
BMI categories (HR 1.10, 1.29, and 1.93 for underweight,
overweight, and obese, respectively; normal was reference);
after adjustment for clinical variables, the HRs were 1.21,
1.14, and 1.52, respectively. In addition to the baseline
covariates, the adjusted HRs for AF were not attenuated in
models adjusted for interim MI or heart failure (HR: 1.20
[95% conﬁdence interval [CI], 0.99–1.44; P=0.052]; HR: 1;
1.14 [95% CI, 1.06–1.23; P<0.001]; HR: 1.53 [95% CI,
1.31–1.79; P<0.001] for underweight, normal, overweight,
and obese, respectively). To assess the inﬂuence of
different degrees of WC, we estimated regressions with 2
WC categories (normal and abdominal obesity). Age- and
sex-adjusted HRs (1.35) and clinical variable–adjusted HRs
(1.18) for WC increased across these 2 WC categories.
General overweight or obese status and abdominal obesity
Table 1. Baseline Characteristics of Participants by the Level of BMI and WC Category Among Koreans
Overall
(n=501 690)
BMI (kg/m2) WC (cm)
Underweight
(n=20 987)
Normal
(n=320 478)
Overweight
(n=141 129)
Obese
(n=19 096)
Abdominal
Obesity ()
(n=358 916)
Abdominal
Obesity (+)
(n=142 594)
Age, y 47.614.3 41.517.3 47.114.4 49.813.4 46.614.0 45.513.9 53.113.9
Male, n (%) 250 940 (50.0) 6140 (29.3) 150 913 (47.1) 83 955 (59.5) 10 018 (52.5) 193 850 (54.0) 57 091 (40.0)
Height, cm 163.49.2 162.38.1 163.29.0 164.09.7 163.810.6 164.08.8 161.810.0
Weight, kg 63.511.8 46.45.1 59.28.2 72.29.2 86.312.5 60.710.1 70.612.8
BMI, kg/m2 23.73.3 17.60.8 22.21.7 26.81.3 32.12.4 22.52.5 26.73.0
WC, cm 80.09.4 66.05.7 76.67.0 87.26.3 97.07.8 76.27.3 89.66.8
HF, n (%) 10 937 (2.2) 286 (1.4) 5442 (1.7) 4351 (3.1) 858 (4.5) 4861 (1.4) 6072 (4.3)
HTN, n (%) 107 925 (21.5) 1974 (9.4) 56 401 (17.6) 42 661 (30.2) 6889 (36.1) 55 692 (15.5) 52 192 (36.6)
DM, n (%) 64 132 (12.8) 1537 (7.3) 35 216 (11.0) 23 593 (16.7) 3786 (19.8) 34 505 (9.6) 29 600 (20.8)
Previous MI, n (%) 4555 (0.9) 152 (0.7) 2504 (0.8) 1648 (1.2) 251 (1.3) 2565 (0.7) 1988 (1.4)
CKD or ESRD, n (%) 29 264 (5.8) 1000 (4.8) 17 538 (5.5) 9532 (6.8) 1194 (6.3) 17 268 (4.8) 11 984 (8.4)
Ischemic stroke/TIA, n (%) 18 461 (3.7) 557 (2.7) 10 317 (3.2) 6668 (4.6) 919 (4.7) 9547 (2.7) 8907 (6.2)
Vascular disease, n (%) 39 295 (7.8) 974 (4.8) 21 784 (6.9) 14 421 (10.0) 2116 (10.8) 20 660 (5.8) 18 620 (13.1)
CHA2DS2-VASc 1.191.38 1.201.20 1.131.30 1.281.52 1.431.59 0.961.17 1.751.67
SBP, mm Hg 12215 11314 12015 12715 13115 12015 12715
DBP, mm Hg 7610 7110 7510 7910 8211 7510 7910
Fasting glucose, mg/dL 97.924.8 91.221.3 96.123.4 101.826.5 106.031.1 95.722.8 103.228.6
Total cholesterol, mg/dL 194.937.3 178.433.0 192.136.3 202.238.1 205.239.3 191.636.0 203.439.1
Triglyceride, mg/dL 132.093.9 84.055.6 118.382.3 162.6106.9 181.5118.4 121.187.1 159.5104.2
HDL-cholesterol, mg/dL 56.427.2 64.229.0 57.927.5 52.626.1 51.224.6 57.627.6 53.326.2
LDL-cholesterol, mg/dL 113.737.2 98.733.5 111.936.4 118.838.3 119.539.6 111.236.2 119.939.0
Hb, g/dL 13.91.7 13.11.5 13.71.6 14.31.6 14.31.7 13.91.6 13.81.6
Creatinine, mg/dL 1.101.12 1.071.06 1.101.10 1.111.21 1.070.94 1.111.15 1.071.06
AST, mg/dL 25.317.2 23.020.4 24.116.9 27.316.5 31.420.1 24.417.0 27.417.5
ALT, mg/dL 24.822.10 16.717.1 21.819.3 30.624.4 40.732.9 22.820.3 29.925.4
Underweight deﬁned as BMI <18.5; normal, 18.5 to <25.0; overweight, 25.0 to <30.0; and obese, >30.0. Abdominal obesity deﬁned as WC ≥90 cm for men, ≥80 cm for women in Asian.
All P values of 1-way ANOVA and the v2 test for underweight vs normal vs overweight vs obese were <0.001. All P values of the Student t test or v2 test for abdominal obesity () vs
abdominal obesity (+) were <0.001. ALT indicates alanine transaminase; AST, aspartate transaminase; BMI, body mass index; CHA2DS2-VASc, congestive heart failure, hypertension, age
75 years or older, diabetes mellitus, previous stroke/transient ischemic attack, vascular disease, age 65–74 years, female; CKD, chronic kidney disease; DBP, diastolic blood pressure;
DM, diabetes mellitus; ESRD, end-stage renal disease; Hb, hemoglobin; HDL, high-density lipoprotein; HF, heart failure; HTN, hypertension; LDL, low-density lipoprotein; MI, myocardial
infarction; SBP, systolic blood pressure; TIA, transient ischemic attack; WC, waist circumference.
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accounted for 12.4% and 20.2%, respectively, of the
population-attributable risk.
In Cox proportional hazards models using covariates
including age, sex, and BMI as a 1-SD increase, WC as a 1-
SD (9.4 cm) increase independently increased the risk of
new-onset AF, whereas BMI as a 1-SD (3.7) increase was not
signiﬁcant after adjusting for age, sex, and WC as a 1-SD
increase (WC—HR: 1.18 [95% CI, 1.11–1.26; P<0.001]; BMI
—HR: 1.04 [95% CI, 0.99–1.10; P=0.121]).
Inﬂuence of Abdominal Obesity for New-Onset AF
in Different BMI Categories
Figure 2A shows the relationship between BMI and WC. WC
was positively correlated with BMI. The patients who devel-
oped AF during the follow-up period are marked with black
points (Figure 2B). The ratio of new-onset AF in participants
with abdominal obesity was higher than that in those without
abdominal obesity in the underweight (2.7% versus 0.6%,
P<0.001), normal (1.1% versus 0.5%, P<0.001) and over-
weight groups (1.0% versus 0.6%, P<0.001) in contrast to the
obese group (1.0% versus 1.0%, P=0.99).
Figure 3 shows the Kaplan–Meier curves for new-onset AF
according to abdominal obesity in patients with different BMI
categories. Abdominal obesity was associated with new-onset
AF in the underweight (P<0.001), normal (P<0.001), and
overweight groups (P<0.001) but not in the obese group
(P=0.894).
Inﬂuence of Abdominal Obesity for New-Onset AF
Risk in Patients With Different Comorbidities and
Habits of Smoking and Alcohol
The HR of abdominal obesity for new-onset AF in patients with
different comorbidities and habits of smoking and alcohol are
presented in Figure 4. Age-adjusted HRs for new-onset AF by
abdominal obesity were 1.44 (95% CI, 1.32–1.58; P<0.001) in
men and 1.23 (95% CI, 1.11–1.37; P<0.001) in women. After
adjustment for age and sex, abdominal obesity by WC was a
risk factor for new-onset AF in nonobese participants (HR:
1.30; 95% CI, 1.21–1.40; P<0.001) but not in obese
individuals (HR: 0.74; 95% CI, 0.35–1.60; P=0.446).
Participants with abdominal obesity showed an increased
risk of new-onset AF regardless of diabetes mellitus, smoking
Figure 1. Kaplan–Meier curves for incidental AF risk across categories of body mass index (A) and waist circumference (B). AF indicates
atrial ﬁbrillation.
Table 2. Incidence of Atrial Fibrillation by BMI and WC Categories
BMI (kg/m2) WC (cm)
Underweight Normal Overweight Obese Abdominal Obesity () Abdominal Obesity (+)
Numbers of events/person-y 121/75 358 1907/1 225 534 1231/559 989 183/72 002 1963/1 385 832 1479/547 052
AF incidence per 1000 person-y 1.61 1.56 2.20 2.54 1.42 2.70
Underweight deﬁned as BMI <18.5; normal, 18.5 to <25.0; overweight, 25.0 to <30.0; and obese, >30.0 of BMI. Abdominal obesity deﬁned as WC ≥90 cm for men and ≥80 cm for women
in Asians. AF indicates atrial ﬁbrillation; BMI, body mass index; WC, waist circumference.
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history, or heavy alcohol use (all P<0.001). However, age-
and sex-adjusted HRs for new-onset AF signiﬁcantly
increased in patients without hypertension (HR: 1.43; 95%
CI, 1.28–1.61; P<0.001), congestive heart failure (HR: 1.36;
95% CI, 1.17–1.47; P<0.001), previous MI (HR: 1.35; 95% CI,
1.25–1.45; P<0.001), and chronic kidney disease or end-
stage renal disease (HR: 1.41; 95% CI, 1.31–1.53; P<0.001)
compared with their respective counterparts with these
conditions.
Relationship of LA Size to BMI and WC
Additional analysis was performed in 1037 consecutive AF
patients (mean age: 5811 years; 248 [23.9%] women) who
were admitted to Severance Hospital from 2009 to 2015 to
evaluate the relationship of LA size to BMI and WC. Baseline
characteristics and echocardiographic ﬁndings are shown in
Table S2. In linear regressions, both BMI and WC demon-
strated signiﬁcantly positive correlations with LA size
(b=2.40, P<0.001 for BMI; b=2.19, P<0.001 for WC). Our
hospital data showed that WC tended to increase the risk of
LA enlargement after age, sex, and BMI adjustment, but it did
not reach statistical signiﬁcance (odds ratio: 1.24; 95% CI,
0.97–1.59; P=0.081).
Discussion
Main Findings
The main ﬁndings of this study are as follows. First, the
nationwide community-based data indicate that general
obesity and abdominal obesity are risk factors for AF. The
association between obesity and subsequent AF development
was still observed after accounting for concomitant condi-
tions, such as hypertension, diabetes mellitus, congestive
heart failure, and MI. Second, abdominal obesity is a risk
factor for AF in nonobese, but not in obese, Asian populations.
Finally, WC was related to the increased risk of AF in persons
without comorbidities, such as hypertension, congestive heart
failure, previous MI, and renal disease. These data increase
the possibility that interventions to decrease abdominal
obesity may reduce the population burden of AF in Asian
populations.
Effect of General Obesity as Quantiﬁed by BMI on
New-Onset AF Risk
In a range of community-based cohorts, general obesity and
increased BMI are associated with increased AF risk (HR
1.65–2.35) at follow-up.5,7,30–33 In the Women’s Health Study
(mean age: 567 years), each 1-kg/m2 increase in BMI is
associated with a 5% increased risk of AF over a 13-year
follow-up. Similarly, each 1-kg/m2 increase in BMI adjusted
for age and sex was associated with a 5% increased risk of AF
in the present study. Overweight status was identiﬁed as a
Table 3. AF Risk of BMI or WC According to the Age-, Sex-,
and Clinical Variable–Adjusted Model in the Total Population
Model
Overall
HR (95% CI) P Value
With BMI as a 1-SD (3.7) increase
Age, sex adjusted 1.17 (1.13–1.21) <0.001
Age, sex, and WC adjusted 1.04 (0.99–1.10) 0.121
Adjusted for clinical variables* 1.08 (1.05–1.12) <0.001
With BMI as a categorical variable
Age, sex adjusted
Underweight (<18.5) 1.10 (0.92–1.32) 0.308
Normal (18.5 to <25) 1
Overweight (25 to <30) 1.29 (1.20–1.38) <0.001
Obese (≥30) 1.93 (1.65–2.24) <0.001
Age, sex, and WC adjusted
Underweight (<18.5) 1.14 (0.94–1.37) 0.182
Normal (18.5 to <25) 1
Overweight (25 to <30) 1.17 (1.07–1.27) <0.001
Obese (≥30) 1.65 (1.40–1.94) <0.001
Adjusted for clinical variables*
Underweight (<18.5) 1.21 (1.01–1.46) 0.041
Normal (18.5 to <25) 1
Overweight (25 to <30) 1.14 (1.06–1.23) <0.001
Obese (≥30) 1.52 (1.30–1.78) <0.001
With WC as a 1-SD (9.4-cm) increase
Age, sex adjusted 1.23 (1.18–1.27) <0.001
Age, sex, and BMI adjusted 1.18 (1.11–1.26) <0.001
Adjusted for clinical variables* 1.12 (1.08–1.17) <0.001
With WC as a categorical variable
Age, sex adjusted
Abdominal obesity, without 1
Abdominal obesity, with 1.35 (1.26–1.45) <0.001
Age, sex, and BMI adjusted
Abdominal obesity, without 1
Abdominal obesity, with 1.20 (1.10–1.31) <0.001
Adjusted for clinical variables*
Abdominal obesity, without 1
Abdominal obesity, with 1.18 (1.10–1.26) <0.001
BMI indicates body mass index; CI, conﬁdence interval; HR, hazard ratio; WC, waist
circumference.
*Clinical variables were age, sex, hypertension, diabetes mellitus, dyslipidemia,
congestive heart failure, chronic kidney disease or end-stage renal disease, history of
previous myocardial infarction, transient ischemic attack or stroke history, smoking
history, and heavy alcohol use.
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risk factor for AF, contributing a 10-year population-
attributable risk of 12% in the Women’s Health Initiative
study (mean age: 637 years).28 Black participants had a
lower AF incidence rate by 41% compared with white
participants in the Women’s Health Initiative study. BMI
>35 is also associated with increased AF risk by an HR of
3.50 in young (30.64.7 years), otherwise healthy women in
a nationwide cohort study from Denmark.34
Multiple plausible biological pathways link body fat and
lean body mass to AF occurrence. Height, weight, and body
Figure 2. Relationship between body mass index and waist circumference in total population (A) and participants with new-onset AF (B).
AF indicates atrial ﬁbrillation.
Figure 3. Kaplan–Meier curve for developing AF in participants who were underweight (A), normal (B), overweight (C), and obese (D).
AF indicates atrial ﬁbrillation.
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fat predispose to LA enlargement, which in turn predisposes
to AF.35,36 Higher BMI is associated with inﬂammation, which
is reﬂected in higher concentrations of C-reactive protein.37 In
addition, general obesity is a major risk factor for obstructive
sleep apnea; sleep apnea predisposes to AF.30 Finally, general
obesity predisposes to the intermediate occurrence of
hypertension, diabetes mellitus, acute MI, heart failure, and
heart valve disease, which in turn increase the risk of AF.38
Inﬂuence of Abdominal Obesity for New-Onset AF
in Different BMI Categories
Assessments of the associations between different types of
obesity (visceral versus subcutaneous) and AF are limited. WC
and hip circumference and waist-to-hip circumference ratio
are associated with AF risk. In community-dwelling cohorts,
increased WC and waist-to-hip circumference ratio are
associated with 11% to 13% higher risk of AF over a 13- to
15-year follow-up period.4,8,39 Elevated body fat mass has
been recently associated with a 29% increased risk of AF
during a 13.5-year follow-up period.4 In this study, abdominal
obesity assessed by WC was positively associated with 35%
increase risk of AF after adjustment for age and sex during
follow-up. Findings from the current study suggest that
abdominal obesity is positively associated with AF risk in
Asian persons; however, a nonlinear J-shaped association was
found between continuous BMI variables and AF risk—AF risk
positively increased with the increase of WC. Aronis et al
reported that BMI, abdominal circumference, and total fat
mass are associated with risk of AF among white and black
older adults.40 The LEGACY study demonstrated the beneﬁcial
effects of long-term sustained weight loss and participation in
Figure 4. Age- and sex-adjusted HRs for the effect of abdominal obesity on incident atrial ﬁbrillation in subgroups. Heavy alcohol use was
deﬁned as >1 drink per day for women and >2 drinks per day for men. BMI indicates body mass index; CKD, chronic kidney disease; ESRD, end-
stage renal disease; HR, hazard ratio; MI, myocardial infarction.
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a tailored exercise program on reducing AF recurrence in
obese persons.41 Obesity reduction can modify the incidence
of AF.40 Nevertheless, there are limited data assessing the
association between risk of AF and abdominal obesity in Asian
populations.
In the present study, compared with participants without
abdominal obesity as quantiﬁed by WC, those with abdominal
obesity showed increased AF risk in all BMI categories except
those in the obese group. The Asian population currently has
a lower prevalence of obese persons than the Western
population.17 Obese participants also had the lowest number
among the other groups in our cohort. The World Health
Organization expert consultation suggests that Asian popula-
tions have different associations among BMI, percentage of
body fat, and disease risks than European populations.17
Asians tend to have higher percentages of abdominal fat at
any given BMI18; therefore, BMI does not fully capture
information on abdominal obesity. Thus, WC measurement
may have additional associations with prospective risk of AF,
particularly in Asian populations. The observation that the HRs
of WC for obese Asian population that had cardiovascular risk
factors did not reach statistical signiﬁcance may reﬂect either
a threshold effect or reduced statistical power to detect an
effect among this population.
The 1000 person-year incidence of new-onset AF was
higher in patients with abdominal obesity than in those
without abdominal obesity in the underweight (8.50 versus
1.55, P<0.001), normal (2.75 versus 1.39, P<0.001) and
overweight groups (2.71 versus 1.47, P<0.001). This ﬁnding
suggests that abdominal obesity may have a role in increasing
AF risk in nonobese Asian persons. Given that BMI is generally
lower in Asian populations than in Western populations,
abdominal obesity may be a more important, potentially
modiﬁable risk factor for AF in nonobese Asian patients.
WC increased the risk of AF in all subgroups except in
patients with hypertension, congestive heart failure, previous
MI, and chronic kidney disease or end-stage renal disease.
These comorbidities are important factors affecting increased
AF risk.26,42 Concomitant comorbidities in these subgroups
may, in part, account for the attenuation of the effect of
abdominal obesity on incident AF from these factors in the
present study. Previous studies have observed that overweight
status, obesity, and high WC may be associated with favorable
prognosis—referred to as the “obesity paradox”—in patients
with cardiovascular disease.43–47 In populations with severe
comorbidities (heart failure, renal disease), obesity may also
have protective effects against AF (the obesity paradox).
Study Limitations
This study has several limitations. First, this study includes a
potential selection bias. The NHIS recommends but does not
obligate all health insurance subscribers to undergo at least 1
biennial health examination. Second, we could not analyze
initial, paroxysmal, persistent, and permanent AF and atrial
ﬂutter separately. Finally, the possible variations in their
relationships to anthropometric features could not be con-
ﬁrmed.
Conclusion
Although AF incidence gradually increased as BMI or WC
increased, abdominal obesity as quantiﬁed by WC is associ-
ated with AF incidence, even after adjustments of other risk
factors in participants without general obesity. This ﬁnding
suggests that AF risk may be more affected by WC, and
decreasing abdominal obesity may reduce the population
burden of AF in nonobese Asian persons.
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Supplemental Material 
Table S1. Definition of diagnoses, comorbidity, and outcomes from NHIS-NSC / Yonsei 
University. 
Diagnosis of Comorbidities 
Atrial fibrillation Defined from diagnosis* ICD10: I48 
Ischemic stroke Defined from diagnosis* ICD10: I63, I64 
TIA Defined from diagnosis* ICD10:  G45 
Arterial 
embolism 
Defined from diagnosis* ICD10: I74 
Hemorrhagic 
stroke 
Defined from diagnosis* ICD10: I60, I61, I62 
Heart failure Defined from diagnosis* ICD10: I11.0, I50, I97.1 
Diabetes mellitus Defined from diagnosis* ICD10: E10, E11, E12, E13, E14 
Hypertension Defined from diagnosis* ICD10: I10, I11, I12, I13, I15 
Previous MI Defined from diagnosis* I21, I22, I25.2 
Peripheral 
arterial disease 
Defined from diagnosis* 
ICD10: I70.0, I70.1, I70.2, I70.8, 
I70.9, I73.9, I79.2 
Dyslipidemia Defined from diagnosis* ICD10: E78 
COPD Defined from diagnosis* J42, J43(except J43.0), J44 
Osteoporosis Defined from diagnosis* M80, M81, M82 (except M82.0) 
Chronic kidney 
disease 
Defined from eGFR eGFR <60 mL/min per 1.73 m
2 
ESRD 
Defined from national registry 
for severe illness. 
Patients with ESRD undergoing 
chronic dialysis or received a kidney 
transplant. 
Malignancy 
Defined from diagnoses of 
cancer (non-benign) 
ICD10: C00-C97 
Potential absence 
of non-valvular 
atrial fibrillation 
Defined from any diagnoses or 
operation of mitral stenosis 
ICD10: I05.0, I05.2, I34.2, Z95.2-4 
Chronic Liver 
disease 
Defined from diagnosis 
of  chronic liver disease, 
cirrhosis, and hepatitis 
ICD10: B18, K70, K71, K72, K73, 
K74, K76.1 
   
 
Outcomes 
New onset atrial 
fibrillation (AF) 
Defined from diagnosis* without 
previous insurance claim for AF 
ICD10: I48 
Ischemic stroke Defined  from death or admission 
diagnosis of ischemic stroke 
ICD10: I63, I64 
Arterial embolism Defined  from death or admission 
diagnosis of arterial embolism 
ICD10: I74 
Bleeding Defined from death or admission 
diagnosis of gastrointestinal, 
intracranial, respiratory, and urinary 
tract bleedings; and anemia caused by 
bleeding 
ICD10: I60-I62, I690-I692, 
J942, K250, K254, K260, 
K264, K270, K280, K920-
K922, N02, R04, R31, S064-
S066,  
Acute 
myocardial 
infarction 
(MI) 
Defined from death or admission 
diagnosis of acute MI 
I21, I22 
Sudden 
cardiac arrest 
Defined from death or admission 
diagnosis 
I46 
 
*To ensure accuracy, comorbidities were established based on one inpatient or two outpatient 
records of ICD-10 codes in the database. 
Table S2. Baseline Characteristics and echocardiographic findings of Severance Hospital 
Data 
 Severance Hospital Data* (n=1,037) 
Age (years)  58.1±11.2 
Male, n (%)  789(76.1) 
Height, cm 167.6±8.2 
Weight, kg  70.1±10.9 
BMI, kg/m2 24.9±2.8 
WC, cm 90.6±8.9 
HF, n (%) 60(5.8) 
HTN, n (%) 506(48.8) 
DM, n (%)  163(15.7) 
Ischemic stroke/TIA, n (%)  122(11.8) 
Vascular disease, n (%) 174(16.8) 
CHA2DS2_VASc 1.73±1.62 
Echocardiographic finding  
  LVEF, % 62.7±8.4 
  LA size, mm 41.3±6.1 
  E/Em 10.5±5.6 
  LAE†, n(%) 246(23.7) 
 
*1,037 consecutive atrial fibrillation patients who visited to Severance Hospital from 2009 to 
2015. 
†LAE defined as left atrial diameter more than 45 mm 
BMI, body mass index; CHADS2, heart failure, hypertension, age ≥75 years, diabetes 
mellitus, stroke; DM, diabetes mellitus; HF, heart failure; HTN, hypertension; LAE, left 
atrium enlargement; TIA, transient ischemic attack; VASc, Vascular disease, age 65-75 years, 
sex category; WC, waist circumference  
Figure S1. Spline curves between BMI and WC, and the hazard ratio of new-onset AF. 
 
Whereas there was a non-linear J-shaped association between continuous BMI variables and 
AF risk (A), AF risk increased positively as WC increased (B). 
